These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

894 related articles for article (PubMed ID: 33981029)

  • 1. Glucose-lowering treatments and COVID-19 mortality in T2DM.
    Hadjadj S; Wargny M
    Nat Rev Endocrinol; 2021 Jul; 17(7):387-388. PubMed ID: 33981029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can glucose-lowering drugs affect the prognosis of COVID-19 in patients with type 2 diabetes?
    Schernthaner G
    Lancet Diabetes Endocrinol; 2021 May; 9(5):251-252. PubMed ID: 33798462
    [No Abstract]   [Full Text] [Related]  

  • 3. Change in glucose-lowering medication regimens in individuals with type 2 diabetes mellitus during the COVID-19 pandemic in Germany.
    Jacob L; Rickwood S; Rathmann W; Kostev K
    Diabetes Obes Metab; 2021 Apr; 23(4):910-915. PubMed ID: 33319440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and Diabetes.
    Singh AK; Khunti K
    Annu Rev Med; 2022 Jan; 73():129-147. PubMed ID: 34379444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of type 2 diabetes and its management on the prognosis of patients with severe COVID-19.
    Xu Z; Wang Z; Wang S; Ye Y; Luo D; Wan L; Yu A; Sun L; Tesfaye S; Meng Q; Gao L
    J Diabetes; 2020 Dec; 12(12):909-918. PubMed ID: 32638507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review.
    Berlie HD; Kale-Pradhan PB; Orzechowski T; Jaber LA
    Ann Pharmacother; 2021 Nov; 55(11):1386-1396. PubMed ID: 33657863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England.
    Khunti K; Knighton P; Zaccardi F; Bakhai C; Barron E; Holman N; Kar P; Meace C; Sattar N; Sharp S; Wareham NJ; Weaver A; Woch E; Young B; Valabhji J
    Lancet Diabetes Endocrinol; 2021 May; 9(5):293-303. PubMed ID: 33798464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
    Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
    Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inpatient use of metformin and acarbose is associated with reduced mortality of COVID-19 patients with type 2 diabetes mellitus.
    Li J; Wei Q; McCowen KC; Xiong W; Liu J; Jiang W; Thomas RL; Hepokoski M; He M; Shyy JYJ; Malhotra A; Xiong N; Li WX
    Endocrinol Diabetes Metab; 2022 Jan; 5(1):e00301. PubMed ID: 34585841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term use of sodium-glucose co-transporter-2 inhibitors on plasma volume status in patients with type 2 diabetes mellitus: Sub-analysis of a prospective, observational study during the COVID-19 pandemic.
    Patoulias D; Papadopoulos C; Zografou I; Katsimardou A; Imprialos K; Stavropoulos K; Tranidou A; Karagiannis A; Doumas M
    Kardiol Pol; 2022; 80(1):80-82. PubMed ID: 34783355
    [No Abstract]   [Full Text] [Related]  

  • 11. Pre-diabetes and COVID-19, could we be missing the silent killer?
    Sosibo AM; Khathi A
    Exp Biol Med (Maywood); 2021 Feb; 246(4):369-370. PubMed ID: 33215530
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impacts of Type 2 Diabetes on Disease Severity, Therapeutic Effect, and Mortality of Patients With COVID-19.
    Wang X; Liu Z; Li J; Zhang J; Tian S; Lu S; Qi M; Ma J; Qiu B; Dong W; Xu Y
    J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32979271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing type 2 diabetes mellitus during COVID-19 pandemic: The bittersweet.
    Yehya A; Carbone S
    Diabetes Metab Res Rev; 2021 Jan; 37(1):e3360. PubMed ID: 32488991
    [No Abstract]   [Full Text] [Related]  

  • 15. [The Management of Blood Glucose Should be Emphasized in the Treatment of COVID-19].
    Ma WX; Ran XW
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 51(2):146-150. PubMed ID: 32220179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic Therapy and Mortality in Very Old Patients With Diabetes Hospitalized due to COVID-19.
    Ramos-Rincón JM; Pérez-Belmonte LM; Carrasco-Sánchez FJ; Jansen-Chaparro S; De-Sousa-Baena M; Bueno-Fonseca J; Pérez-Aguilar M; Arévalo-Cañas C; Bacete Cebrian M; Méndez-Bailón M; Fiteni Mera I; González García A; Navarro Romero F; Tuñón de Almeida C; Muñiz Nicolás G; González Noya A; Hernández Milian A; García García GM; Alcalá Pedrajas JN; Herrero García V; Corral-Gudino L; Comas Casanova P; Meijide Míguez H; Casas-Rojo JM; Gómez-Huelgas R;
    J Gerontol A Biol Sci Med Sci; 2021 Jul; 76(8):e102-e109. PubMed ID: 33945610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis.
    Zhao LM; Chen XH; Qiu M
    Front Endocrinol (Lausanne); 2021; 12():825100. PubMed ID: 35082762
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes, Drug Treatment, and Mortality in COVID-19: A Multinational Retrospective Cohort Study.
    Nyland JE; Raja-Khan NT; Bettermann K; Haouzi PA; Leslie DL; Kraschnewski JL; Parent LJ; Grigson PS
    Diabetes; 2021 Dec; 70(12):2903-2916. PubMed ID: 34580086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID 19: Diabetes and Obesity API-ICP Recommendations.
    Joshi SR; Tiwaskar MH; Shah SN
    J Assoc Physicians India; 2020 May; 68(5):42-44. PubMed ID: 32610865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extremely high-dose insulin requirement in a diabetic patient with COVID-19: a case report.
    Jornayvaz FR; Assouline B; Pugin J; Gariani K
    BMC Endocr Disord; 2020 Oct; 20(1):155. PubMed ID: 33066762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.